Pathstone Family Office’s Inovio Pharmaceuticals INO Stock Holding History

Pathstone Family Office’s Portfolio INO Stock Details INO Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$57.7K	Buy
2023 Q2	$22.4K	Buy
2023 Q1	$29.1K	Sell
2022 Q4	$124K	Sell
2022 Q3	$141K	Buy
2022 Q2	$73.1K	Buy
2022 Q1	$72K	Sell
2021 Q4	$101K	Buy
2021 Q3	$137K	Buy
2021 Q2	$149K	Buy